This study reveals a CUL3–EHMT2–Aurora B regulatory axis that safeguards accurate chromosome segregation in PCa cells, supporting the potential therapeutic application of EHMT2 inhibitors. The gene discussed is AURKB; the disease is posterior cortical atrophy.